中国实用妇科与产科杂志

中国实用妇科与产科杂志 ›› 2022, Vol. 38 ›› Issue (1): 29-32.DOI: 10.19538/j.fk2022010108

• 专题笔谈 • 上一篇    下一篇

卵巢癌手术质量控制

  

  1. 中国医学科学院北京协和医院妇产科，北京 100730
  • 出版日期:2022-01-02 发布日期:2022-01-02
  • 通讯作者: 曹冬焱
  • 基金资助:
    国家自然科学基金（81101976）

Quality control of surgery for ovarian cancer. 

  1. Department of Obstetrics & Gynecology，Peking Union Medical College Hospital，Peking Union Medical College，Chinese Academy of Medical Sciences，Beijing 100730，China
  • Online:2022-01-02 Published:2022-01-02

摘要： 减瘤术是治疗卵巢癌最关键的手段之一，手术的目标是在病人可耐受的前提下，最大程度地切除一切原发及继发肿瘤。由妇科肿瘤医生施行的高质量的减瘤术是改善卵巢癌预后和延长生存的重要保证。卵巢癌的手术质量控制包括：（1）术前的专业评估与决策。（2）高水平的专业的减瘤术技巧。（3）术后规范的组织病理学报告。多学科团队（MDT）合作在卵巢癌的手术治疗中发挥关键作用。

关键词: 卵巢肿瘤, 手术治疗, 质量控制, 多学科团队

Abstract: Cyto-reductive surgery is the most important therapeutic option for patients with ovarian cancer. The goal of surgery is to achieve RO resection，which means thorough resection of both primary and metastatic tumors. High-quality surgery performed by gynecological oncologists is essential to improving the prognosis of patients with ovarian cancer and their survival.  The quality control of cyto-reductive surgery includes （1）professional preoperative evaluation and decision-making；（2）high-level professional surgical procedures；（3）postoperation standardized histological examinations and reports. Multi-disciplinary team co-operation plays an essential role in the surgical management of ovarian cancer.

Key words: ovarian cancer, surgical treatment, quality control, MDT

中图分类号: